Nurix Therapeutics Inc is trading 5% up today at $18.43, extending a strong multi-day rebound that began after last week’s double-digit gain.
- The stock continues to trade well below the consensus analyst price target range of the high-$20s to low-$30s.
- Sentiment remains positive with multiple Buy ratings and significant implied upside from firms including Jefferies, BTIG, H.C. Wainwright, Needham, and UBS.
- The upward move comes despite no new company-specific news or filings hitting major wires so far this morning.